Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Lafont

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|May 20, 2021
Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive MechanismsVirginie Lafont, Sophie Lucas, Nathalie Bonnefoy
Advances in Experimental Medicine and Biology|February 16, 2020
IL-21 Signaling in the Tumor MicroenvironmentGhita Chabab, Nathalie Bonnefoy, Virginie Lafont
Frontiers in Immunology|July 6, 2026
Editorial: Community series in new insights into innate immune cell-based immunotherapies in cancer, volume IIChiara Porta, Mary Poupot-Marsan, Virginie Lafont
Frontiers in Immunology|October 12, 2020
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for TherapyGhita Chabab, Clément Barjon, Nathalie Bonnefoy, et al.
Protein Science : a Publication of the Protein Society|October 17, 2002
Functional aspects of co-variant surface charges in an antibody fragmentNicolas Hugo, Virginie Lafont, Mervyn Beukes, et al.
Microbial Pathogenesis|December 2, 2008
The IFNgamma-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophagesSandrine Bouhet, Virginie Lafont, Elisabeth Billard, et al.
Frontiers in Immunology|April 24, 2024
Editorial: New insights into innate immune cell-based immunotherapies in cancerAnne Caignard, Mary Poupot-Marsan, Virginie Lafont, et al.
European Journal of Immunology|April 7, 2011
Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteriaStéphanie Bessoles, Ming Ni, Sara Garcia-Jimenez, et al.
Biochemistry|November 3, 2005
Variations in antigen-antibody association kinetics as a function of pH and salt concentration: a QSAR and molecular modeling studyAnnick Dejaegere, Laurence Choulier, Virginie Lafont, et al.
Proteins|January 30, 2007
Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids"Virginie Lafont, Michael Schaefer, Roland H Stote, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|May 20, 2021
Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive MechanismsVirginie Lafont, Sophie Lucas, Nathalie Bonnefoy
Advances in Experimental Medicine and Biology|February 16, 2020
IL-21 Signaling in the Tumor MicroenvironmentGhita Chabab, Nathalie Bonnefoy, Virginie Lafont
Frontiers in Immunology|July 6, 2026
Editorial: Community series in new insights into innate immune cell-based immunotherapies in cancer, volume IIChiara Porta, Mary Poupot-Marsan, Virginie Lafont
Frontiers in Immunology|October 12, 2020
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for TherapyGhita Chabab, Clément Barjon, Nathalie Bonnefoy, et al.
Protein Science : a Publication of the Protein Society|October 17, 2002
Functional aspects of co-variant surface charges in an antibody fragmentNicolas Hugo, Virginie Lafont, Mervyn Beukes, et al.
Microbial Pathogenesis|December 2, 2008
The IFNgamma-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophagesSandrine Bouhet, Virginie Lafont, Elisabeth Billard, et al.
Frontiers in Immunology|April 24, 2024
Editorial: New insights into innate immune cell-based immunotherapies in cancerAnne Caignard, Mary Poupot-Marsan, Virginie Lafont, et al.
European Journal of Immunology|April 7, 2011
Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteriaStéphanie Bessoles, Ming Ni, Sara Garcia-Jimenez, et al.
Biochemistry|November 3, 2005
Variations in antigen-antibody association kinetics as a function of pH and salt concentration: a QSAR and molecular modeling studyAnnick Dejaegere, Laurence Choulier, Virginie Lafont, et al.
Proteins|January 30, 2007
Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids"Virginie Lafont, Michael Schaefer, Roland H Stote, et al.
Pageof 4